Classic stair-step to the stars....and they've got the rocket power with the Merger for it to rise to mind blowing heights!
A perfect storm setting up for that to happen as follows:
1). Merger (should be complete by quote: "mid-November" according to email response sent to me today by CCBT Investor Relations based on me asking for this information!
2). Extremely small Float, i.e. 59.0 Million, totally unheard of for a Biotech Company.
3). Post Merger, combined with streamline in-house capacity for product development and commercialization, translates into faster sales delivery to end users on a global level with serious cash flow earnings hitting their bottom line! This will surely attract Institutional Investors and Hedge Funds and also a higher percentage of Insider Ownership more than it already is! i.e. like maybe going from 1.4% (as of today) to 30% or higher! The lower the available float for trading, the higher the PPS rises!
4). Institutional-Hedge Fund Investors as a result of #3 that will undoubtedly begin snapping up a large percentage of the 4M Float when all the above comes onto their radar! This by itself could send the PPS North of $100/share from single dollar digit levels in a single trading session! I've seen it happen!
PPS after a solid year of all the above this time next year? My estimate: $20-$50 per share, easily!
Biotech's have a well established history of trading at 40-80X earnings, and some with ZERO EARNINGS are known to trade above $8. Take CytoDyn for example, a Penny Stock with a 52 week trading history of $0.52-to-$10,(12/3/19 -6/30/20), presently trading at $2.50, and today they still have NO EARNINGS! Have a look for yourself.
Near term PPS IMO: $1 rising to $5 between December 2020 to end of 1st Quarter 2021.
All aboard! Last call for penny level buy in!
Please keep in mind everyone that Amazon & Apple were once Penny Stocks!
News 
Market Data 
Discover 
AI
